Variable | Total (n = 1544) | Group A: No surgery of primary site (n = 403) | Group B: Local therapy (n = 532) | Group C: Radical surgery of primary site (n = 582) | p value (A vs. B) | p value (A vs. C) | p value (B vs. C) |
---|---|---|---|---|---|---|---|
Age at diagnosis | 0.142 | <0.001* | <0.001* | ||||
Mean (SD) | 69.54 (13.03) | 70.4 (13.52) | 73.02 (12.85) | 65.8 (11.89) | |||
Race | 0.001* | 0.833 | 0.003* | ||||
White | 1164 (75.4) | 288 (71.5) | 431 (81.0) | 422 (72.5) | |||
Black | 290 (18.8) | 84 (20.8) | 81 (15.2) | 121 (20.8) | |||
Other | 90 (5.8) | 31 (7.7) | 20 (3.8) | 39 (6.7) | |||
Sex | <0.001* | 0.903 | <0.001* | ||||
Male | 971 (62.9) | 233 (57.8) | 385 (72.4) | 333 (57.2) | |||
Female | 573 (37.1) | 170 (42.2) | 147 (27.6) | 249 (42.8) | |||
Grade | <0.001* | <0.001* | <0.001* | ||||
I | 70 (5.1) | 25 (6.2) | 27 (5.1) | 26 (4.5) | |||
II | 290 (18.8) | 70 (17.4) | 84 (15.8) | 130 (22.3) | |||
III | 457 (29.6) | 123 (30.5) | 126 (23.7) | 203 (34.9) | |||
IV | 376 (24.4) | 66 (16.4) | 168 (31.6) | 139 (23.9) | |||
Unknown | 342 (22.2) | 119 (29.5) | 127 (23.9) | 84 (14.4) | |||
Histology | <0.001* | 0.040* | <0.001* | ||||
SCC | 437 (28.3) | 130 (32.2) | 95 (17.9) | 205 (35.2) | |||
TCC | 660 (42.7) | 146 (36.2) | 305 (57.3) | 198 (34.0) | |||
AC | 252 (16.3) | 59 (14.6) | 77 (14.5) | 111 (19.1) | |||
Other | 195 (12.6) | 68 (16.9) | 55 (10.3) | 68 (11.7) | |||
T stage | <0.001* | <0.001* | <0.001* | ||||
T0/T1 | 521 (33.7) | 109 (27.0) | 274 (51.7) | 131 (22.5) | |||
T2 | 315 (20.4) | 56 (13.9) | 110 (20.8) | 147 (25.3) | |||
T3 | 318 (20.6) | 78 (19.4) | 54 (10.2) | 179 (30.8) | |||
T4 | 180 (11.7) | 62 (15.4) | 35 (6.6) | 81 (13.9) | |||
Tx | 207 (13.4) | 97 (24.1) | 57 (10.8) | 44 (7.6) | |||
N stage | <0.001* | <0.001* | <0.001* | ||||
N0 | 1040 (67.5) | 206 (51.2) | 416 (78.5) | 403 (69.2) | |||
N1 | 149 (9.7) | 60 (14.9) | 23 (4.3) | 63 (10.8) | |||
N2 | 154 (10.0) | 51 (12.7) | 33 (6.2) | 69 (11.9) | |||
Nx | 198 (12.8) | 85 (21.1) | 58 (10.9) | 47 (8.1) | |||
M stage | <0.001* | <0.001* | 0.041* | ||||
M0 | 1245 (80.8) | 258 (64.2) | 451 (85.1) | 517 (88.8) | |||
M1 | 158 (10.3) | 96 (23.9) | 38 (7.2) | 22 (3.8) | |||
Mx | 138 (9.0) | 48 (11.9) | 41 (7.7) | 43 (7.4) | |||
AJCC stage groups | <0.001* | <0.001* | <0.001* | ||||
I | 432 (28.2) | 68 (16.9) | 247 (47.0) | 111 (19.2) | |||
II | 228 (14.9) | 38 (9.5) | 84 (16.0) | 104 (18.0) | |||
III | 264 (17.2) | 48 (11.9) | 42 (8.0) | 170 (29.4) | |||
IV | 392 (25.6) | 158 (39.3) | 84 (16.0) | 145 (25.1) | |||
Unknown | 217 (14.2) | 90 (22.4) | 69 (13.1) | 48 (8.3) | |||
Tumor size, mm (n = 642) | <0.001* | 0.041* | 0.007* | ||||
Mean (SD) | 38.27 (24.31) | 44.30 (24.18) | 30.20 (19.82) | 38.88 (25.01) | |||
Radiation | <0.001* | <0.001* | 0.641 | ||||
Yes | 403 (26.1) | 146 (36.2) | 113 (21.2) | 116 (19.9) | |||
No/Unknown | 1141 (73.9) | 257 (63.8) | 419 (78.8) | 466 (80.1) | |||
Chemotherapy | <0.001* | 0.006* | 0.011* | ||||
Yes | 477 (30.9) | 161 (40.0) | 129 (24.2) | 182 (31.3) | |||
No/Unknown | 1067 (69.1) | 242 (60.0) | 403 (75.8) | 400 (68.7) |